Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortizatization of Intangibles: 2023-2025

Historic Amortizatization of Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 3 years, with Sep 2025 value amounting to $285,184.

  • Cumberland Pharmaceuticals' Amortizatization of Intangibles changed negligibly% to $285,184 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 16.28%. This contributed to the annual value of $1.1 million for FY2024, which is 36.70% up from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Amortizatization of Intangibles is $285,184, which was down 0.00% from $285,185 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Amortizatization of Intangibles registered a high of $296,150 during Q2 2023, and its lowest value of $125,479 during Q4 2023.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Amortizatization of Intangibles value was $285,184 (recorded in 2025), while the average stood at $257,345.
  • Over the last 5 years, Cumberland Pharmaceuticals' Amortizatization of Intangibles had its largest YoY gain of 127.28% in 2024, and its largest YoY loss of 3.70% in 2024.
  • Quarterly analysis of 3 years shows Cumberland Pharmaceuticals' Amortizatization of Intangibles stood at $125,479 in 2023, then soared by 127.28% to $285,185 in 2024, then remained steady at $285,184 in 2025.
  • Its Amortizatization of Intangibles stands at $285,184 for Q3 2025, versus $285,185 for Q2 2025 and $285,184 for Q1 2025.